Bioassays for carcinogenicity of various primary processing products (crude oils or tars) and commercial products obtained from Estorian oil shale have been carried out since 1951. The products (undiluted or diluted) were painted twice weekly 50 times on the interscapular area of the skin of random-bred or CC57Br mice. The products processed at high temperatures have a higher carcinogenic activity. Blends of products containing over 10% of high temperature crude oil (chamber furnace oil) have about the same carcinogenic activity as the latter. There is no strict correlation between the concentration of benzo(a)pyrene (BP) in oil shale products and their carcinogenic activity. Determination of BP in such products can serve as an approximate estimate of carcinogenic properties.
The main results of animal experiments carried out since 1951 to determine the carcinogenic potency of various primary and commercial products of thermolysis of oil shale from deposits in northeastern Estonia (USSR) will be briefly summarized. Attention will also be drawn to some questions of more general interest, such as the value of determination of benzo(a)pyrene (BP) in such products and the role of solvents.
Previous studies on the carcinogenic action of Scottish oil shale processing products (1) (2) (3) (4) were familiar to us as were publications on occupational tumors induced by various tars and oils in the Scottish oil shale industry, cotton spinning, and other industries (5) (6) (7) (8) (9) .
The carcinogenic activity of primary oil shale tars from other Soviet oil shale deposits (Veimarn, Gdov) was comparatively weak (10, 11) . Larionov (12) tested some tars obtained from Estonian oil * Institut Eksperimental'noI i Klinichesko'l Meditsiny, Tallinn, Est. S.S.R.
June 1979 shales and found that only the tar from the chamber oven pilot plant, produced at temperatures up to 1000°C, possesses carcinogenic properties.
In our earlier experiments we used random-bred white mice in skin painting experiments. Undiluted (later also diluted) products were applied twice weekly (50 times) on the interscapular area of the skin. Periodic examinations of skin changes and post mortems with histological investigations of changes in various organs were performed. In most cases the BP concentrations in products under investigation was carried out in the Institute of Chemistry of the Academy of Sciences of the Estonian SSR. The criterion of malignancy was the histological demonstration of penetration of the tumor into the muscular layer. Table I shows the results of experiments with six samples of primary processing products of oil shale which we call tars or crudes; of these, the chamber oven tar is processed at about 1000°C, while the generator, tunnel oven, and solid heat carrier tars are processed at temperatures ranging from 400 to 5500C.
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The effective number of mice is the number alive at the time of appearance of the first tumor. Table 2 presents data on the carcinogenicity of some commercial products. The carcinogenic activity in commercial products containing the highly carcinogenic chamber oven tar is obvious; on the other hand, the carcinogenicity of various samples of chamber oven tar is different, and there is no clear relationship between the proportion of chamber oven tar in complex mixtures and their carcinogenic potency. Table 3 presents data on carcinogenicity of asphalts produced by three different methods from heavy fractions of low temperature tars. The oxidized (blown) asphalt containing considerably less BP is less carcinogenic than the bottom asphalt obtained as residue of vacuum distillation of these heavy fractions. The cold solvent extraction residue appeared to be even less carcinogenic, in spite of slightly higher BP concentration. The light fraction obtained in the solvent extraction process with approximately similar BP content had a considerably stronger carcinogenicity. Apparently the BP concentration and carcinogenic potency are not completely correlated. Table 4 shows some results of later experiments by Vinkmann carried out with some commercial products mostly in CC57Br mice. There is a near, but not complete, correlation between the BP concentration and the carcinogenicity of the product. Some tars have been repeatedly tested as their composition was not absolutely constant; the results however are in general similar.
The main conclusion which can be drawn from these tests is that the higher carcinogenic activity occurs in the products processed at high temperature. Even a blend of tars containing over 10% of chamber oven tar has about the same carcinogenic These fractions were also injected intramuscularly to mice and painted on the skin of rabbits. Some interesting results were obtained including data on remote tumors in lungs and on skin mastocytomas, which have been published elsewhere (15) . Figure 1 shows the difference in the development of skin tumors in mice, presenting the carcinogenic effect.
Fraction 7 with the same amount of BP as the solution of pure BP in benzene contains probably compounds lengthening the latency period of the carcinogenic effect of BP. Fraction 5 without BP apparently consists of rather active carcinogenic compounds other than BP and fraction 4 containing no BP has a moderately enhancing effect on the action of fraction 6.
We have cooperated in an effort to diminish the contact of workers with the strongly carcinogenic chamber oven tar. Together with Kozhevnikov and Gortalum (16) experiments on coking of the chamber oven tar, analyses of BP content of the liquid products involved (initial products and coke distillate), and experiments on the action of the distillate in comparison with the initial tar on mice were carried out.
The initial tar contained 2300 ppm BP, the distillation residue (the immediate material for coking) 6400 ppm, the distillate (after coking), 535 ppm BP. Random-bred mice were painted 50 times (twice weekly) with 15% benzene solutions of the initial tar and the distillate. The results are shown in Table 6 .
The distillate has a considerably weaker carcinogenic effect than the initial tar. On the other hand, the concentration of BP again does not corre- Figure 2 shows that the dephenolated chamber oven tar, the solution of BP in benzene, and the fraction 7 of the chamber oven tar, all three containing 2000 ppm BP show different degrees of carcinogenic potency, the strongest carcinogenicity was found in the 15 per cent dilution of chamber oven tar in medicinal vaseline containing about ten times less of BP.
Vaseline consists of various aliphatic hydrocarbons. The strong potentiating activity of ndodecane, one representative of such compounds, was clearly demonstrated by Bingham and Falk (17) .
These results have substantial practical significance, as small amounts of known carcinogenic compounds may under certain circumstances be much more dangerous than could be concluded from their actual concentrations.
Bingham and Falk also discussed the promoting CHART 2 FIGURE 1. Carcinogenic effect of various fractions of chamber oven oil. role of phenols (17) . Our second paper deals with some data on phenols present in oil shale processing products. From the theoretical point of view as well as from various practical aspects it would appear very important to investigate whether aliphatic hydrocarbons act synergistically with the carcinogen, facilitating its penetration into the cells, or in another way, do they have a phenollike promoting action which can manifest itself after some time has passed, after exposure to the carcinogen. It is necessary to find out whether aliphatic hydrocarbons are active as promoters in the sense of the two-stage scheme of carcinogenicity.
These considerations should be especially taken into account if oil shale processing products should be used as lubricants, cooling mixtures, or cutting oils. This concerns undoubtedly all mineral oils.
An important practical conclusion can be made that dilution of oil shale processing products with "'neutral" products, such as refined mineral oils or similar, consisting mainly of aliphatic hydrocarbons, can by no means be considered as diminishing the carcinogenic potency of these products.
